|
Volumn 272, Issue 5263, 1996, Pages 805-
|
Monkey study prompts high-level public health response
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LEVONORGESTREL;
MEDROXYPROGESTERONE ACETATE;
ORAL CONTRACEPTIVE AGENT;
PROGESTERONE;
CONTRACEPTIVE AGENT;
ANIMAL EXPERIMENT;
FEMALE;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RISK;
MONKEY;
NONHUMAN;
ORAL CONTRACEPTION;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SHORT SURVEY;
SIMIAN IMMUNODEFICIENCY VIRUS;
ANIMAL;
ARTICLE;
DISEASE MODEL;
DISEASE TRANSMISSION;
DRUG EFFECT;
EPITHELIUM;
HAPLORHINI;
HUMAN;
MONKEY DISEASE;
PHYSIOLOGY;
RISK FACTOR;
VAGINA;
VIROLOGY;
ANIMALIA;
HUMAN IMMUNODEFICIENCY VIRUS;
SIMIAE;
SIMIAN IMMUNODEFICIENCY VIRUS;
ANIMALS;
CONTRACEPTIVE AGENTS, FEMALE;
DISEASE MODELS, ANIMAL;
EPITHELIUM;
FEMALE;
HAPLORHINI;
HIV INFECTIONS;
HUMANS;
LEVONORGESTREL;
MEDROXYPROGESTERONE 17-ACETATE;
PROGESTERONE;
RISK FACTORS;
SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;
SIMIAN IMMUNODEFICIENCY VIRUS;
VAGINA;
|
EID: 0030578022
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.272.5263.805 Document Type: Short Survey |
Times cited : (5)
|
References (0)
|